| Financial Year |
March 31 2023 |
| Monetary Funds |
130,628,911.18 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
134,702,645.21 |
| Advances to Suppliers |
2,234,574.18 |
| Other Receivables |
106,292,570.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,032,992.92 |
| Total Current Assets |
384,891,693.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
55,040,494.39 |
| Fixed Assetes |
136,816,475.71 |
| Under-construction Projects |
45,173,432.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
214,569,898.07 |
| R&D expenses |
-- |
| Goodwill |
64,492,373.30 |
| Long-Term Deferred and Prepaid Expenses |
30,926,061.35 |
| Deferred Income Tax Assets |
46,197.49 |
| Other Non-Current Assets |
175,033,550.24 |
| Sub-Total of Non-Current Assets |
725,796,652.33 |
| Total Assets |
1,110,688,346.02 |
| Short-Term Loans |
1,081,097,065.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
117,622,051.85 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,905,996.51 |
| Taxes Payable |
12,164,040.67 |
| Interest Payable |
128,627,969.84 |
| Dividend Payable |
-- |
| Other payables |
218,472,045.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
66,245,627.20 |
| Other Current Liabilities |
153,934.97 |
| Sub-Total of Current Liabilities |
1,505,162,002.61 |
| Long-term Loans |
255,078,642.13 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
50,609,582.73 |
| Deferred Income Tax Liabilities |
56,467.02 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
316,621,138.11 |
| Total Liabilities |
1,821,783,140.72 |
| Paid-In Capital(Or Share Stock) |
704,033,281.00 |
| Capital Surplus |
1,094,250,557.01 |
| Surplus Reserve |
176,897,618.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,689,323,376.33 |
| Minority Stockholder's Interest |
3,047,125.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-714,141,919.97 |
| Owner's Equity（Stockholder's Equity） |
-711,094,794.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,110,688,346.02 |
